Pharmacies across the UK should be contracted by local commissioning services to provide a take-home naloxone service, a government advisory board has said.
Naloxone is currently available in some pharmacies in the UK and in all pharmacies in Edinburgh, but the Advisory Council on the Misuse of Drugs (ACMD) has called for this to be extended to all pharmacies in the UK.
This recommendation comes as part of a report from the ACMD which reviewed the availability and use of naloxone in the UK, a drug used to reverse opioid overdose.
Related Article: Thinktank recommends 'fluid' supervision throughout ARRS career
The report also recommended that pharmacists and pharmacy staff receive training on how to provide naloxone and how to administer both intranasal and intramuscular naloxone.
There are ‘many advantages’ to pharmacies being able to supply naloxone kits, particularly as a ‘core group of people using drugs will visit pharmacies to access opioid substitution,’ said the body.
Pharmacies are a ‘key provider of take-home naloxone (THN) in several regions of England’, ACMD explained.
Since 2015, 717 (19%) kits supplied by pharmacies have been administered in an overdose situation, compared with 4% provided by the drug treatment service.
‘This suggests that in some parts of England, pharmacies are reaching those encountering overdose situations more often than drug treatment services,’ ACMD said.
Related Article: Hub and spoke changes expected to come into force in October
Currently in Scotland, it is recommended that all pharmacies stock naloxone for use in an emergency, and to supply to those who may witness an overdose.
Meanwhile in Wales, it is recommended that THN is provided on an opt-out basis through community pharmacy needle and syringe programme.
However, the report called for a UK-wide agreement on the specific role of community pharmacies in supplying naloxone would be a useful way of promoting collaborative working in all areas of the UK’.
The report comes after a sharp rise in the number of overdoses connected to heroin.
Related Article: New NPA chair takes over alongside first female vice chair
Results of a consultation on naloxone, published in March, found that almost all respondents believed that allowing pharmacists to provide a supply of ‘take-home’ naloxone without a prescription would help reduce overdoses and drug-related deaths.
This comes as part of a wider consultation, launched by the Department of Health and Social Care (DHSC), which has looked into changing a law that would mean naloxone could be supplied without a prescription by roles such as pharmacists, nurses and police officers.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.